Daiichi Sankyo Worldwide

×

17th International Congress on Infectious Diseases

2nd - 5th March 2016, Hyderabad, India
The International Society for Infectious Diseases held its first ever conference in India at Hyderabad on 2nd-5th March 2016. DSIN was a premier sponsor for this event. The conference, entitled "17th International Congress on Infectious Diseases", encompassed all aspects of human infections including the diagnosis and treatment of bacterial diseases (childhood pneumonia, CRE, drug-resistant tuberculosis, etc.), HIV, viral hepatitis, dengue, malaria, encephalitis, visceral lieshmanaiasis, and antifungal prophylaxis and treatment. The conference allowed the 1,890 delegates from 97 countries to gain insight on future research prospects for infectious diseases. Abstracts from approximately 1,500 researchers from 94 countries were submitted to the conference but only 880 were accepted. The conference was epitomized by accounts of recent scientific research relevant to both the Indian sub-continent and the world stage given in 6 plenary lectures, 40 talks and 834 posters.

As a PREMIER sponsor of the conference, DSIN was given a unique opportunity to showcase the company to a global community of investigators, practitioners, innovators, scientists and researchers, not only through the organizer's own pronouncements (e.g. conference, e-mail correspondence, brochures, websites, billboards, fliers, etc.) but also by the use of a dedicated office in which conference attendees could learn more about Daiichi Sankyo. The office served as a place for specific discussions between members of the 15 strong DSIN delegation with invited Key Opinion Leaders (KOLs). Such discourse helped our scientists formulate research plans, identify authorities for future interactions, and publicize the work of DSIN to experts in the field. We also shared our own recent research findings in the form of a lecture and five posters, and this was well appreciated by the attending scientific community. Our scientists participated actively with researchers from across the globe, thereby acquiring greater scientific knowledge and building the brand of DSIN.

The Plenary lecturers offered a wide coverage of infectious diseases. Prof. ShiraneeSriskandan (UK) discussed the nature of molecular interactions between host & pathogens which are responsible for lymphatic tropism. Prof. C. L. Lai (China) and Prof. N. White (Thailand) gave overviews of the past, present and future direction of hepatitis B and malaria research, respectively. Prof. SaumayaSwaminathan (Director, ICMR) highlighted the need to recognise regional variations in phenotypes of TB isolates and presented an extensive review of current and future therapeutics for TB. She emphasized the immediate need for advanced computational support to search large sets of clinical data in order to make meaningful conclusions for policy makers. Dame Sally Davies,Chief Medical Officer (England) gave an excellent overview ofantimicrobial resistance "from Problem to Policy to Action". She emphasized the necessity for both conservative and innovative approaches if we are to successfully make antibiotics available for future generations. Prof. P. Tambyah (Singapore) presented an interesting comparative study of Zyka, MERS, Ebola, SARS & H1N1 epidemics.

On returning to Gurgaon, the DSIN delegates shared their experiences and highlighted future trends in antibiotic drug discovery with the RCI Discovery Leadership Team.

Company Profile

As a global company, we aim to constantly extend our business activities.